EMEA-002048-PIP02-18

Key facts

Active substance
Givosiran
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0038/2019
PIP number
EMEA-002048-PIP02-18
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of Acute Hepatic Porphyria
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Alnylam UK Limited
Tel. +1  8663300326
E-mail: clinicaltrials@alnylam.com
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating